Wedbush Securities’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-14,880
| Closed | -$131K | – | 867 |
|
|
2017
Q2 | $131K | Sell |
14,880
-26,215
| -64% | -$231K | 0.02% | 758 |
|
|
2017
Q1 | $214K | Sell |
41,095
-15,395
| -27% | -$80.2K | 0.03% | 664 |
|
|
2016
Q4 | $172K | Sell |
56,490
-23,530
| -29% | -$71.6K | 0.03% | 685 |
|
|
2016
Q3 | $370K | Buy |
80,020
+18,450
| +30% | +$85.3K | 0.06% | 431 |
|
|
2016
Q2 | $356K | Sell |
61,570
-500
| -0.8% | -$2.89K | 0.06% | 389 |
|
|
2016
Q1 | $376K | Sell |
62,070
-300
| -0.5% | -$1.82K | 0.07% | 337 |
|
|
2015
Q4 | $569K | Sell |
62,370
-24,710
| -28% | -$225K | 0.1% | 217 |
|
|
2015
Q3 | $491K | Buy |
87,080
+10,185
| +13% | +$57.4K | 0.1% | 236 |
|
|
2015
Q2 | $853K | Buy |
76,895
+2,880
| +4% | +$31.9K | 0.16% | 152 |
|
|
2015
Q1 | $1.16M | Buy |
74,015
+37,035
| +100% | +$581K | 0.2% | 110 |
|
|
2014
Q4 | $562K | Buy |
36,980
+570
| +2% | +$8.66K | 0.09% | 238 |
|
|
2014
Q3 | $393K | Buy |
+36,410
| New | +$393K | 0.06% | 326 |
|